Avidity Biosciences, Inc.
NASDAQ:RNA
29.08 (USD) • At close December 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 185.082 | 340.396 | 405.543 | 328.141 | 94.578 | 3.09 |
| Short Term Investments
| 410.269 | 270.331 | 85.095 | 6.679 | 0 | 0 |
| Cash and Short Term Investments
| 595.351 | 610.727 | 405.543 | 328.141 | 94.578 | 3.09 |
| Net Receivables
| 1.105 | 0 | 0.9 | 1.2 | 0 | 0 |
| Inventory
| 0 | 0 | -0.9 | -1.2 | 0 | 0 |
| Other Current Assets
| 14.851 | 8.34 | 5.598 | 3.537 | 1.098 | 0.304 |
| Total Current Assets
| 611.307 | 622.942 | 411.141 | 331.678 | 95.676 | 3.242 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 16.652 | 15.009 | 15.589 | 1.468 | 0.631 | 0.702 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.251 | 0.251 | 0.251 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.596 | 0.598 | 0.599 | 0.501 | 0.6 | 0.038 |
| Total Non-Current Assets
| 17.248 | 15.858 | 16.439 | 2.22 | 1.231 | 0.74 |
| Total Assets
| 628.555 | 638.8 | 427.58 | 333.898 | 96.907 | 3.982 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 8.809 | 4.637 | 2.806 | 7.745 | 2.308 | 1.565 |
| Short Term Debt
| 14.836 | 6.21 | 3.538 | 0 | 2.774 | 2.746 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 28.365 | 5.041 | 4.864 | 3.69 | 3.84 | 0 |
| Other Current Liabilities
| 39.867 | 60.85 | 27.96 | 3.152 | 1.314 | 0.305 |
| Total Current Liabilities
| 80.68 | 51.908 | 29.658 | 14.587 | 10.236 | 4.616 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 6.213 | 15.164 | 19.92 | 1.876 | 2.163 | 7.578 |
| Deferred Revenue Non-Current
| 40.898 | 1.235 | 6.532 | 12.15 | 15.1 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | -1.235 | -6.532 | -12.15 | 134.72 | 0 |
| Other Non-Current Liabilities
| 0 | -7.582 | -9.96 | -0.938 | 0.045 | 32.917 |
| Total Non-Current Liabilities
| 47.111 | 8.817 | 16.492 | 13.088 | 152.028 | 40.495 |
| Total Liabilities
| 127.791 | 60.725 | 46.15 | 27.675 | 162.264 | 45.111 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 333.898 | 134.72 | 32.693 |
| Common Stock
| 0.008 | 0.007 | 0.005 | 0.004 | 0.001 | 0.426 |
| Retained Earnings
| -570.764 | -358.544 | -184.549 | -66.54 | -22.185 | -41.555 |
| Accumulated Other Comprehensive Income/Loss
| 0.125 | -2.698 | -0.187 | -0.005 | -134.721 | -33.119 |
| Other Total Stockholders Equity
| 1,071.395 | 939.31 | 566.161 | 372.764 | 91.549 | 33.119 |
| Total Shareholders Equity
| 500.764 | 578.075 | 381.43 | 306.223 | -65.357 | -41.129 |
| Total Equity
| 500.764 | 578.075 | 381.43 | 306.223 | -65.357 | -41.129 |
| Total Liabilities & Shareholders Equity
| 628.555 | 638.8 | 427.58 | 333.898 | 96.907 | 3.982 |